Key facts
- This page summarizes Michael A. Smith's Form 4 filing for INSMED Inc (INSM).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Jul 2021, 16:54.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.
Footnote F2
Each Restricted Stock Unit was received as a grant on July 8, 2021, for no consideration.
Footnote F3
In connection with the appointment of Mr. Smith as the Company's General Counsel, Senior Vice President, the Company granted Mr. Smith an option to purchase a total of 32,550 shares of the Company's common stock under the Company's 2019 Incentive Plan. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Mr. Smith's continued employment with the Company on each vesting date.